ImmuCell Corporation (ICCC) — Financial statements
Income statement, balance sheet, and cash flow for ImmuCell Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 28↑4.3% | 26↑51.6% | 17↓5.9% | 19↓3.5% | 19 | |
| Cost of Revenue | 16↓12.7% | 19↑41.9% | 13↑19.7% | 11↑3.1% | 11 | |
| Gross Profit | 11↑44.1% | 8↑80.6% | 4↓42.5% | 8↓11.6% | 9 | |
| Operating Expenses | ||||||
| R&D Expenses | 3↓22.0% | 4↓11.3% | 4↓2.2% | 4↑7.8% | 4 | |
| General & Administrative Expenses | 3↑44.4% | 2↑3.9% | 2↓5.7% | 2↑31.2% | 2 | |
| Selling & Marketing Expenses | 4↑2.5% | 3↑12.2% | 3↓3.2% | 3↑27.4% | 3 | |
| SG&A Expenses | 7↑18.9% | 6↑8.8% | 5↓4.2% | 5↑28.9% | 4 | |
| Other Expenses | 0.00 | 0.00↓100.0% | 0.53 | 0.00 | 0.00 | |
| Operating Expenses | 10↑2.2% | 10↓5.6% | 10↑2.0% | 10↑18.4% | 8 | |
| Total Costs & Expenses | 26↓7.6% | 28↑21.2% | 23↑11.3% | 21↑9.9% | 19 | |
| Operating Results | ||||||
| Operating Income | 2↑200.6% | -2↑71.5% | -6↓150.0% | -2↓993.2% | 0.26 | |
| Depreciation & Amortization | 3↑1.6% | 3↓1.1% | 3↑9.2% | 2↑1.1% | 2 | |
| EBITDA | 2↑100.6% | 1↑142.6% | -3↓815.5% | 0.35↓87.0% | 3 | |
| EBIT | -0.59↑63.6% | -2↑69.0% | -5↓144.3% | -2↓1000.5% | 0.24 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.28↑42.9% | -0.49 | 0.00↑100.0% | -0.20↑33.9% | -0.30 | |
| Interest Income | 0.16↑104.3% | 0.08 | 0.00↓100.0% | 0.15↑713.9% | 0.02 | |
| Interest Expense | 0.44↓22.8% | 0.57 | 0.00↓100.0% | 0.35↑10.9% | 0.31 | |
| Non-Operating Income | 2↑11495.9% | -0.02↑96.3% | -0.53↓226.6% | -0.16↓907.0% | 0.02 | |
| Other Income / Expenses | -3↓428.8% | -0.51↓2213.1% | -0.02↑88.3% | -0.19↑42.8% | -0.33 | |
| Income Before Tax | -1↑52.1% | -2↑62.8% | -6↓132.1% | -2↓3496.0% | -0.07 | |
| Income Tax Expense | 0.01↑15.1% | 0.01↑117.3% | 0.00↓42.2% | 0.01↓12.7% | 0.01 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -1↑51.8% | -2↑62.7% | -6↓131.6% | -2↓3085.3% | -0.08 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -1↑51.8% | -2↑62.7% | -6↓131.5% | -2↓3085.5% | -0.08 | |
| Bottom-Line Net Income | -1↑51.8% | -2↑62.7% | -6↓131.6% | -2↓3085.3% | -0.08 | |
| EPS (Basic) | -0.12↑53.8% | -0.26↑65.3% | -0.75↓134.4% | -0.32↓3006.8% | -0.01 | |
| EPS (Diluted) | -0.12↑53.8% | -0.26↑65.3% | -0.75↓134.4% | -0.32↓3006.8% | -0.01 | |
| Weighted Average Shares | 9↑10.5% | 8↑6.1% | 8↓0.6% | 8↑2.0% | 8 | |
| Weighted Average Diluted Shares | 9↑10.5% | 8↑5.4% | 8↑0.0% | 8↑2.0% | 8 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.